Upgrade to SI Premium - Free Trial

Acadia Pharmaceuticals (ACAD) PT Lowered to $30 at RBC Capital

March 12, 2024 6:24 AM
RBC Capital analyst Gregory Renza ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles